Compare Moderna, Inc. (MRNA) vs Microsoft (MSFT) Price & Performance

Moderna, Inc.Trade

MicrosoftTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs Microsoft — how do they compare? Moderna, Inc. trades at $60.61 (market cap $24.18B), while Microsoft trades at $500.34 (market cap $3.74T). The key difference: Microsoft is far larger — about 154.7× Moderna, Inc.'s market cap, and Microsoft pays a 0.72% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.

	MRNA	MSFT
Market Cap	$24.18B	$3.74T
Sector	Health	Technology
52-Week High	$81.80	$542.07
52-Week Low	$22.36	$352.83
Enterprise Value	$20.33B	$3.72T
Volume	—	36,654,621
Dividend Yield	—	0.72%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Moderna, Inc.

No Aura AI signal available yet.

Microsoft

Microsoft (MSFT) trades at $506.06, up 1.21% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with $281.72B revenue, 40.31% net margin, and consistent earnings beats. Analyst consensus remains overwhelmingly positive with 80.49% buy ratings and $552.73 price target, representing 9.2% upside potential. Recent news highlights Microsoft's AI leadership and cloud computing strength.

Microsoft presents a compelling investment case with strong financial performance and AI-driven growth prospects. Key opportunities include Azure cloud expansion and Copilot adoption, while risks involve increased capital expenditures and competitive pressures. The stock's current valuation at 28.19 P/E appears reasonable given growth trajectory, though investors should monitor execution on AI investments and macroeconomic conditions affecting tech spending.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

View details →

MSFT

150MW Carwarp Energy Park in Australia starts operation, powering 65,000 homes with clean energy.PRNewsWire · 4 hours agoBullish Microsoft stock jumps 20%, but high valuation limits further upside, says investor.Seeking Alpha · 18 hours agoBearish Fidelity Dividend ETF's payout is safe but not ideal for steady income due to variable quarterly dividends.24/7 Wall Street · 22 hours agoNeutral View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About Microsoft

Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.